$ALT (-0,44%) is now performing again after the last trial report and crash.

Of course, there is a lot of risk at this early stage.

Let's see how the FDA sees it later on.

Current developments against:

* Obesity and its associated diseases

* MASH (Metabolic Dysfunction-Associated Steatohepatitis)

* Alcohol use disorder (AUD)

* Alcohol-Associated Liver Disease (ALD)

Earnings next week (11.11 - 15.11)

$SHOP (+3,64%)

$SOUN

$MARA (+1,14%)

$BABA (+1,49%)

$CAVA

$SPOT (-4,02%)

$AMAT (+1,63%)

$DIS (-1,22%)

$PLUG (+1,6%)

$HD (+0,28%)

$MNDY (+0,25%)

$OXY (-0,43%)

$RKLB (+1,36%)

$BSEM

$ZETA (+1,25%)

$SE (-1,48%)

$RKT

$CSCO (+0,2%)

$ASTS (+2,82%)

$WULF (+6,05%)

$ONON (-1,37%)

$OKLO

$HUT (+17,18%)

$NVAX (+1,88%)

$HTZ (+0,22%)

$LUNR

$CART

$TALN

$BITF (+11,33%)

$GRAB (+1,94%)

$JD (+0%)

$LAZR

$ALT (-0,44%)

$CRON (+2,34%)

$ICL

$NICE

$CYBR (+0,7%)

$BXSL (+0,79%)

$DESP

$ARMK (+0,32%)

$TSN (-0,61%)

$RUM

$PGY

$TGI

$AAP (-0,84%)

$AXSM (+1,9%)

$AZN (+0%)

$BILI (+1,61%)

$LINC (+3,72%)

$LQDA (+0,63%)

$ALT (-0,44%) I hope things are looking up😂

$ALT (-0,44%) What do you think of the share?

The share is very exciting and after the drop I am now hoping for a nice return of 20%-30%